Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany
Author
Abstract
Suggested Citation
DOI: 10.1186/2191-1991-4-2
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Mathews, Holly F. & Lannin, Donald R. & Mitchell, James P., 1994. "Coming to terms with advanced breast cancer: Black women's narratives from Eastern North Carolina," Social Science & Medicine, Elsevier, vol. 38(6), pages 789-800, March.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Niehaus, Ines & Dintsios, Charalabos-Markos, 2018. "Confirmatory versus explorative endpoint analysis: Decision-making on the basis of evidence available from market authorization and early benefit assessment for oncology drugs," Health Policy, Elsevier, vol. 122(6), pages 599-606.
- Jörg Ruof & Thomas Staab & Charalabos-Markos Dintsios & Jakob Schröter & Friedrich Wilhelm Schwartz, 2016. "Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany – are additional data requirements by the Federal Joint Committ," Health Economics Review, Springer, vol. 6(1), pages 1-11, December.
- Ingo Stiller & Arjen Witteloostuijn & Bart Cambré, 2021. "Do current radical innovation measures actually measure radical drug innovation?," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(2), pages 1049-1078, February.
- Ruof, Jörg & Knoerzer, Dietrich & Dünne, Anja-Alexandra & Dintsios, Charalabos-Markos & Staab, Thomas & Schwartz, Friedrich Wilhelm, 2014. "Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in Germany," Health Policy, Elsevier, vol. 118(2), pages 242-254.
- C. M. Dintsios & I. Beinhauer, 2020. "The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany," Health Economics Review, Springer, vol. 10(1), pages 1-25, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Kaiser, Karen, 2008. "The meaning of the survivor identity for women with breast cancer," Social Science & Medicine, Elsevier, vol. 67(1), pages 79-87, July.
- Malat, Jennifer R. & van Ryn, Michelle & Purcell, David, 2006. "Race, socioeconomic status, and the perceived importance of positive self-presentation in health care," Social Science & Medicine, Elsevier, vol. 62(10), pages 2479-2488, May.
- Smit, Anri & Coetzee, Bronwynè Jo’sean & Roomaney, Rizwana & Bradshaw, Melissa & Swartz, Leslie, 2019. "Women's stories of living with breast cancer: A systematic review and meta-synthesis of qualitative evidence," Social Science & Medicine, Elsevier, vol. 222(C), pages 231-245.
More about this item
Keywords
AMNOG; German health care reform; Oncology; Endpoints; Progression-free survival; Patient-relevant benefit;All these keywords.
JEL classification:
- D61 - Microeconomics - - Welfare Economics - - - Allocative Efficiency; Cost-Benefit Analysis
- H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-8:10.1186/2191-1991-4-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/13561 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.